![[Next-Generation Sequencing Book]](https://www.bioinformatics.org/images/ack_banners/NGS-Book-1-728x90.png)
-
YOU are highly motivated and are always committed to deliver work of the highest quality. You encourage collaboration and enjoy working in a team. You are a passionate individual who likes creative and international work environments. RESPONSIBILITIES
The successful candidate will join the Biological Systems Research Team at Philip Morris Products S.A. in Neuchatel, Switzerland. He/she will play a major role in the analysis of large scale data sets from various post-genomic technologies together with the practical application of this knowledge in the fields of cancer, cardiovascular disease and chronic obstructive lung diseases.
Specifically, you will:- Have significant experience of array-based and sequencing analysis
- Apply Systems Biology approaches to improve our understanding of gene regulation at the transcriptional, post-transcriptional and post-translational level in specific tissues in order to identify molecular pathways deregulated in disease
- Apply and develop methods for systems wide analysis of gene expression patterns, their transcription factors and epigenetic controls,
- Investigate the role of small RNAs in regulation of gene/protein products which differentiate normal and diseased states
- Use your knowledge to contribute to the systematic design of in-vitro and in-vivo genomics and proteomics experiments.
- Test model-driven hypotheses in in-vitro and in-vivo systems by interfacing with clinical and laboratory scientists.
- Have well developed scientific writing and critical review skills essential for production of concise project reports which represent a coherent synthesis of the biology of the experimental system.
REQUIREMENTS
- PhD in bioinformatics, computational biology, statistical genetics with a very strong background in toxicology (demonstrated track record) – or – PhD in Toxicology (or related discipline), with a demonstrated track record in analysis and interpretation of molecular toxicology data, specifically, high density gene expression data.
- Demonstrated experience in disease pathways, network biology or pharmacogenomics
- Preferably, you also have knowledge in the fields of inflammation, cardiovascular disease and/or cancer
- Track record in experimental design of systems biology studies
- Solid expertise in R/Bioconductor or MATLAB would be a plus
- Demonstrated experience in managing and interpreting large biological data sets
- Fluency in written and spoken English is a must
COMPENSATION
You will be part of the PMI Research & Development Department, whose primary mission is to research and develop new products with the potential to reduce the risks of smoking-related diseases.
You will benefit from working with a dynamic team of professionals, in a multicultural environment.
We offer an excellent salary and benefits package as well as a relocation allowance (where appropriate).ABOUT US
Philip Morris International Inc. (PMI) is the leading international tobacco company, with seven of the world's top 15 brands, including the number one cigarette brand worldwide. PMI's products are sold in approximately 180 countries. In 2010, the company held an estimated 16.0% share of the total international cigarette market outside of the U.S., or 27.6% excluding the People's Republic of China and the U.S.
For more information, see http://www.pmi.comHOW TO APPLY
Want to discover your potential? Come join our team!
If you match our profile and you are interested in joining our dynamic team of professionals, please reply online.
Please apply online at http://www.pmicareers.comARTICLE
Job Code: D3POLICY
PMI is an Equal Opportunity Employer.
![[Photo]](https://www.bioinformatics.org/images/photo.php?photo_id=62465)
Discussion forums: Opportunity: Scientist - COMPUTATIONAL TOXICOGENOMICS (#D3) @ Philip Morris International--Neuchatel, Switzerland
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be logged in to post a reply.